[Inheritance in erythropoietic protoporphyria]

Area of Science:

• Biochemistry
• Genetics
• Dermatology

Background:

• Erythropoietic protoporphyria (EPP) is an inherited disorder of heme biosynthesis.
• It results from protoporphyrin IX accumulation, causing photosensitivity and potential liver disease.
• EPP involves two genes: FECH and ALAS2.

Purpose of the Study:

• To investigate the genetic basis of Erythropoietic protoporphyria (EPP).
• To understand the varying prevalence of EPP across different populations.
• To explore the role of specific genetic mutations in EPP pathogenesis.

Main Methods:

• Analysis of genetic mutations in the FECH and ALAS2 genes.
• Population-based frequency assessment of the IVS3-48C FECH allele.
• Phylogenetic analysis of IVS3-48C haplotypes.

Main Results:

• Over 96% of EPP patients have ferrochelatase (FECH) deficiency, often due to a common hypomorphic allele (IVS3-48C).
• The varying frequency of the IVS3-48C allele explains global EPP prevalence differences.
• X-linked dominant protoporphyria (XLDPP), caused by ALAS2 mutations, accounts for approximately 4% of EPP cases.

Conclusions:

• Genetic variations, particularly in the FECH gene and its common IVS3-48C allele, are key determinants of EPP prevalence.
• The IVS3-48C allele's origin and distribution explain the ethnic variations in EPP.
• Understanding these genetic factors is crucial for EPP diagnosis and management.